Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/445)
- Bobot, S, Cazauvieilh, V, Lefèvre, F, Solignac, J, Mecerli, S, Brunet, P et al.. [Treatment adherence and chronic kidney disease: Psychological aspects, contributing factors, and potential levers]. Nephrol Ther. 2025;21 (6):1-11. doi: 10.1684/ndt.2025.145. PubMed PMID:41164915 .
- Bentegeac, R, Florens, N, Maanaoui, M, Maisons, V, Lanot, A, Bobot, M et al.. ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training. Clin Kidney J. 2025;18 (10):sfaf308. doi: 10.1093/ckj/sfaf308. PubMed PMID:41133180 PubMed Central PMC12541372.
- Tolboom, N, Albert, NL, Braat, AJAT, Snijders, TJ, Tabouret, E, Taillandier, L et al.. From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials. J Nucl Med. 2025; :. doi: 10.2967/jnumed.125.270820. PubMed PMID:41101976 .
- Agripnidis, T, Ayobi, A, Quenet, S, Chaibi, Y, Avare, C, Jacquier, A et al.. Performance of an artificial intelligence tool for multi-step acute stroke imaging: A multicenter diagnostic study. Eur J Radiol Open. 2025;15 :100678. doi: 10.1016/j.ejro.2025.100678. PubMed PMID:40933241 PubMed Central PMC12419105.
- Gargiulo, M, Di-Rocco, C, Panneau, J, Nguyen, J, Marx, T, Haumont, R et al.. Additional In Vivo Study of Arterial Embolization with a Novel Agar-Based Embolic Agent: Feasibility and Efficacy of New-Size Implants for Improved Microcatheter Injectability. Cardiovasc Intervent Radiol. 2025; :. doi: 10.1007/s00270-025-04193-6. PubMed PMID:40925978 .